Recurrence of Graves’ Disease: What Genetics of HLA and PTPN22 Can Tell Us
BackgroundApproximately half of patients diagnosed with Graves’ disease (GD) relapse within two years of thyreostatic drug withdrawal. It is then necessary to decide whether to reintroduce conservative treatment that can have serious side effects, or to choose a radical approach. Familial forms of G...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Frontiers Media S.A.
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/1a8b1671d06a4a40abbe1383abda890f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|